DE60102144D1 - EINE METHODE ZUR HERSTELLUNG VON IgG - Google Patents

EINE METHODE ZUR HERSTELLUNG VON IgG

Info

Publication number
DE60102144D1
DE60102144D1 DE60102144T DE60102144T DE60102144D1 DE 60102144 D1 DE60102144 D1 DE 60102144D1 DE 60102144 T DE60102144 T DE 60102144T DE 60102144 T DE60102144 T DE 60102144T DE 60102144 D1 DE60102144 D1 DE 60102144D1
Authority
DE
Germany
Prior art keywords
igg
igg fraction
iii
fraction
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60102144T
Other languages
English (en)
Other versions
DE60102144T2 (de
Inventor
Inger Andersson
Lars-Olof Lindquist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
Amersham Bioscience AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20279068&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60102144(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amersham Bioscience AB filed Critical Amersham Bioscience AB
Application granted granted Critical
Publication of DE60102144D1 publication Critical patent/DE60102144D1/de
Publication of DE60102144T2 publication Critical patent/DE60102144T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60102144T 2000-03-30 2001-03-29 EINE METHODE ZUR HERSTELLUNG VON IgG Expired - Fee Related DE60102144T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0001128 2000-03-30
SE0001128A SE0001128D0 (sv) 2000-03-30 2000-03-30 A method of producing IgG
PCT/EP2001/003624 WO2001072844A2 (en) 2000-03-30 2001-03-29 A METHOD OF PRODUCING IgG

Publications (2)

Publication Number Publication Date
DE60102144D1 true DE60102144D1 (de) 2004-04-01
DE60102144T2 DE60102144T2 (de) 2004-10-28

Family

ID=20279068

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60102144T Expired - Fee Related DE60102144T2 (de) 2000-03-30 2001-03-29 EINE METHODE ZUR HERSTELLUNG VON IgG

Country Status (15)

Country Link
US (1) US6835379B2 (de)
EP (1) EP1268551B1 (de)
JP (1) JP2003530326A (de)
CN (1) CN1419566A (de)
AT (1) ATE260297T1 (de)
AU (2) AU2001273907B2 (de)
BR (1) BRPI0109740B8 (de)
CA (1) CA2402784A1 (de)
DE (1) DE60102144T2 (de)
IL (1) IL151667A0 (de)
PT (1) PT1268551E (de)
RU (1) RU2266914C2 (de)
SE (1) SE0001128D0 (de)
TR (1) TR200400701T4 (de)
WO (1) WO2001072844A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100451031C (zh) * 2003-09-05 2009-01-14 东丽株式会社 生物体成分组成改变了的溶液的调制方法
ES2380538T3 (es) * 2003-09-05 2012-05-16 Toray Industries, Inc. Método de preparación de una solución para análisis proteómico
EP1532983A1 (de) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulinpräparationen mit erhöhter Stabilität
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
CN100362022C (zh) * 2005-11-07 2008-01-16 中国人民解放军第二军医大学 海螵蛸多糖cps-1及其制备方法和用途
US20070128693A1 (en) * 2005-12-06 2007-06-07 Advantek Serum Laboratories Limited3/F Method for the inactivation and removal of dengue virus from biological samples
WO2007136327A1 (en) * 2006-05-22 2007-11-29 Ge Healthcare Bio-Sciences Ab A method of producing igg
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
SG176256A1 (en) 2009-05-27 2012-01-30 Baxter Int A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
KR20120108989A (ko) 2009-12-18 2012-10-05 시에스엘 리미티드 폴리펩타이드를 정제하는 방법
WO2011090720A2 (en) * 2009-12-29 2011-07-28 Dr. Reddy's Laboratories Ltd Purification of proteins
CA2788863C (en) 2010-02-04 2020-07-07 Reinhard Franz Bolli Immunoglobulin preparation
EP2361636A1 (de) 2010-02-26 2011-08-31 CSL Behring AG Immunglobulinpräparat und Aufbewahrungssystem für ein Immunglobulinpräparat
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
WO2011150284A2 (en) 2010-05-26 2011-12-01 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
MX349005B (es) * 2011-08-26 2017-07-06 Baxalta Inc Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma.
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
CN109966488A (zh) 2012-02-29 2019-07-05 百深公司 周围神经的IgG刺激髓鞘再生
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
CN104231065A (zh) * 2014-09-09 2014-12-24 青岛康大食品有限公司 兔血中球蛋白的纯化制备方法
WO2017066683A1 (en) 2015-10-15 2017-04-20 Plasma Technologies, Llc Methods for extracting proteins from blood plasma
AU2017214678B2 (en) * 2016-02-03 2024-02-01 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
US10815270B1 (en) 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation
CN114746108A (zh) * 2019-09-20 2022-07-12 等离子体技术有限责任公司 治疗性蛋白质组合物和方法
KR20220161332A (ko) 2020-03-31 2022-12-06 다케다 야쿠힌 고교 가부시키가이샤 C-1 억제제 고갈 혈장으로부터 면역글로불린 조제물을 제조하는 방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
ATE122054T1 (de) * 1990-03-22 1995-05-15 Biotest Pharma Gmbh Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates.
DE4118912C1 (de) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
DE59309332D1 (de) * 1993-12-27 1999-03-04 Rotkreuzstiftung Zentratrallab Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
IL121900A (en) 1997-10-07 2001-12-23 Omrix Biopharmaceuticals Ltd A method for the purification of immunoglobulins
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
AU753468B2 (en) * 1998-06-09 2002-10-17 Csl Behring Ag Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren

Also Published As

Publication number Publication date
AU7390701A (en) 2001-10-08
JP2003530326A (ja) 2003-10-14
TR200400701T4 (tr) 2004-05-21
DE60102144T2 (de) 2004-10-28
CA2402784A1 (en) 2001-10-04
RU2002124857A (ru) 2004-02-20
WO2001072844A2 (en) 2001-10-04
US6835379B2 (en) 2004-12-28
US20030143222A1 (en) 2003-07-31
RU2266914C2 (ru) 2005-12-27
EP1268551B1 (de) 2004-02-25
PT1268551E (pt) 2004-07-30
ATE260297T1 (de) 2004-03-15
WO2001072844A3 (en) 2002-04-11
IL151667A0 (en) 2003-04-10
BR0109740B1 (pt) 2015-01-06
EP1268551A2 (de) 2003-01-02
CN1419566A (zh) 2003-05-21
AU2001273907B2 (en) 2006-02-02
BR0109740A (pt) 2003-02-04
SE0001128D0 (sv) 2000-03-30
BRPI0109740B8 (pt) 2021-05-25

Similar Documents

Publication Publication Date Title
DE60102144D1 (de) EINE METHODE ZUR HERSTELLUNG VON IgG
RU2337109C2 (ru) ПРЕПАРАТ ИММУНОГЛОБУЛИНА IgG И СПОСОБ ЕГО ПОЛУЧЕНИЯ
US5886154A (en) Chromatographic method for high yield purification and viral inactivation of antibodies
ATE346861T1 (de) Verfahren zur reinigung und isolierung von viren, aus pflanzenquellen
US6069236A (en) Immunoglobulin G concentrate for therapeutic use and process for producing said concentrate
JPH0231689A (ja) 百日咳トキシンの精製法
US5834420A (en) Fibrinogen concentrate obtained from blood plasma, process and plant for its preparation
TW245768B (en) Method for killing microorganisms
JPS5944320A (ja) Ｃ１不活性化剤の調製方法
MX9701183A (es) Procedimiento de preparacion del virus gripal, antigenos obtenidos y sus aplicaciones.
DK1718673T3 (da) Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det
US20020018985A1 (en) Method for depleting viral and molecular pathogens in a biological material
CN1181782A (zh) 一种从生物原料中制备因子ix的方法
AT381026B (de) Verfahren zur herstellung einer nebenwirkungsfreien igg-immunglobulinloesung fuer die intravenoese applikation
AU726808B2 (en) Process for reducing the concentration of viral and molecular pathogens in a biological material
TWI526214B (zh) 缺乏一種以上致血栓因子的血漿製品之製備方法
ATE285255T1 (de) Verfahren zur inaktivierung von viren
AU726999B2 (en) Process for reducing the concentration of viral and molecular pathogens in a biological material
MXPA06009678A (es) Metodo para proporcionar una preparacion purificada de anticuerpo con virus inocuos
CN115304668A (zh) 一种高效生产α1-抗胰蛋白酶的方法
JPH09301886A (ja) 蛋白質含有組成物およびその製造方法
WO2006137815A3 (en) Method for purifying mixtures of immunoglobulin & albumin

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: HAMMONDS RECHTSANWAELTE PATENTANWAELTE, 80539 MUENCHEN

8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: GE HEALTHCARE BIO-SCIENCES AB, UPPSALA, SE

8339 Ceased/non-payment of the annual fee